News & Analysis as of

Health law-news Education

Read need-to-know updates, commentary, and analysis on Health issues written by leading professionals.
Roetzel & Andress

Offering Advanced Imaging? Remember to Follow These Rules

Roetzel & Andress on

Does your practice offer MRI, PET or CT imaging to Medicare patients? If so, you may not be following the requirements of the Physician Self-Referral Law (commonly referred to as the “Stark” law). The Stark law regulates...more

Katten Muchin Rosenman LLP

HHS Provides Updated Model Notices of Privacy Practices

To help HIPAA covered entities comply with updated rules for substance use disorder patient records, the U.S. Department of Health and Human Services Office of Civil Rights has published updated language for Notices of...more

Troutman Pepper Locke

After FDA’s Policy Shift on Artificial Colors, State Enforcement and Private Litigation Risks Linger

Troutman Pepper Locke on

On February 5, the Food and Drug Administration (FDA) announced a major change in how the agency will regulate claims about artificial colors in foods. In a “Letter to the Food Industry,” the FDA declared that the agency...more

King & Spalding

CMS Releases Updated Guidance on State Directed Payment Programs Affected by Section 71116 of the Working Families Tax Cuts...

King & Spalding on

On February 2, 2026, CMS issued updated guidance on Medicaid state directed payment (“SDPs”) governed by Section 71116 of the “Working Families Tax Cuts Legislation” enacted in the One Big Beautiful Bill Act (“OBBBA”). The...more

King & Spalding

FDA Issues Refuse-to-File Letter for mRNA-based Vaccine BLA

King & Spalding on

The Food and Drug Administration (FDA) has issued a Refuse-to-File (RTF) letter to Moderna, Inc. regarding its Biologics License Application (BLA) for the investigational mRNA-based influenza vaccine “mRNA-1010.” Moderna...more

Stikeman Elliott LLP

Classification of Employers as part of Prevention and Participation Mechanisms

Stikeman Elliott LLP on

Last November, we informed you of the new occupational health and safety obligations arising from the Regulation respecting prevention and participation mechanisms in establishments (the "Regulation"), which came into force...more

Dorsey & Whitney LLP

FCA Basics: Investigations and Compliance

Dorsey & Whitney LLP on

This is the sixth post in the Dorsey FCANow Blog’s FCA Basics Series covering the fundamentals of the False Claims Act (“FCA”), outlining FCA procedure, and highlighting key facets of FCA practice. Today’s post discusses a...more

Husch Blackwell LLP

2025 State Privacy Changes: What Healthcare Leaders Need to Know

Husch Blackwell LLP on

In 2025, eight new U.S. state privacy laws took effect and several states tightened existing regulations, significantly impacting healthcare organizations. Major changes include strengthened opt-out rights, new protections...more

Shook, Hardy & Bacon L.L.P.

Food and Beverage Litigation and Regulatory Update - February 2026

A disaster declaration related to the New World screwworm, an agency's adjusted approach to "no artificial colors" claims, Florida's investigation into pesticides in bread, and more....more

Morgan Lewis

'No Artificial Colors' Claims Get More Colorful As FDA Announces Shift Away from Petroleum-Based Food Dyes

Morgan Lewis on

The US Food and Drug Administration (FDA) recently announced that brands may label their products as without “artificial colors” as long as the colors are not petroleum-based. Although this may provide limited comfort from an...more

Hogan Lovells

False Claims Act Guide 2026 - Year in review and looking ahead

Hogan Lovells on

The 10th Anniversary of the False Claims Act Guide 2026 – Year in review and looking ahead comes at a pivotal moment for False Claims Act (FCA) enforcement. The past year brought significant enforcement momentum alongside...more

Ogletree, Deakins, Nash, Smoak & Stewart,...

Workplace Violence Puts Healthcare Employers at Legal Risk

Workplace violence continues to be a growing challenge affecting healthcare workers. To support workers and avoid fines and other enforcement actions, employers in the healthcare industry may wish to analyze risk factors and...more

McDermott Will & Schulte

Life sciences dealmaking accelerates in 2026: Key insights from EY’s Firepower M&A Report

Life sciences companies are entering 2026 with momentum. According to Ernst and Young’s (EY) 2026 Firepower M&A Report, dealmaking is accelerating — driven not by short-term market shifts, but by long-term strategic...more

McDermott+

McDermott+ Check-Up: February 13, 2026

McDermott+ on

Senate committees continue to examine fraud in federal and state programs. Discussions spanned social services, public benefits, and immigration-related enforcement....more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: Patient Square to Acquire Paradigm From OMERS

McGuireWoods LLP on

Patient Square Capital will acquire Paradigm from OMERS Private Equity, according to a news release. Paradigm, founded in 1991 and based in Walnut Creek, California, is a specialty care management organization focused...more

TNG Consulting

Community Referrals: Helping Stakeholders to Know When and How to Report

TNG Consulting on

Creating a community that is confident in recognizing concerns and making referrals to the Behavioral Intervention Team (BIT) does not happen by accident. The BIT should provide clear education, consistent messaging, and...more

Sheppard Mullin Richter & Hampton LLP

Federal Courts Push Back: Three Decisions Chart a Path for Challenging Administrative Subpoenas

Administrative subpoenas have long been a powerful tool in the federal government’s investigative arsenal. Issued without prior judicial approval and requiring only minimal procedural safeguards, these demands for documents...more

Hogan Lovells

How the EU Biotech Act aims to foster biotech innovation in Europe - Trends in Cell, Tissue, and Gene Therapies

Hogan Lovells on

On 16 December 2025, the European Commission proposed a package of measures to improve resilience, competitiveness, and safety of the EU health sector....more

Maynard Nexsen

2026 Alabama Legislative Update: Regular Session - Week Five

Maynard Nexsen on

Alabama Affordability Protection Plan - This week saw significant movement on several major components of the Alabama Affordability Protection Plan, with lawmakers in both chambers focusing heavily on the growing impact...more

Dinsmore & Shohl LLP

Amendment to Ohio Law Creates Duty of Cooperation for Board of Nursing Licensees

Dinsmore & Shohl LLP on

A change to Ohio law now makes failure to cooperate with a Board of Nursing (“Nursing Board” or “Board”) investigation an explicit and independent ground for the Nursing Board to take disciplinary action. This change, enacted...more

Troutman Pepper Locke

Proposed State AI Law Update: February 16, 2026

Troutman Pepper Locke on

Key point: Last week, chatbot bills crossed chambers in Virginia and Washington, Tennessee’s Senate passed a health care-related AI bill, a Utah bill drew the attention of the Trump administration, and a new bill was...more

Shumaker, Loop & Kendrick, LLP

Client Alert: Health and Human Services Scraps 340B Rebate Pilot Following Court Case; Health Resources and Services...

In a reversal of policy, the U. S. Department of Health and Human Services (HHS) formally abandoned its 2025 340B Rebate Model Pilot Program. This decision follows a series of legal setbacks in federal court and is...more

Hinshaw & Culbertson - Health Care

Healthcare Compliance Considerations as New York Adopts Medical Aid in Dying Law

Governor Kathy Hochul signed the Medical Aid in Dying Act on February 6, 2026, permitting medical aid in dying for terminally ill New York adult residents with a prognosis of death within six months. The law becomes...more

Sheppard Mullin Richter & Hampton LLP

Testing the Boundaries of Artificial Intelligence in Care Delivery: Utah’s Prescription Renewal Pilot Program

In January 2026, the State of Utah, acting through its Department of Commerce’s Office of Artificial Intelligence Policy (“OAIP”), launched a first-in-the-nation pilot permitting an autonomous artificial intelligence (“AI”)...more

Perkins Coie

FDA Relaxes Enforcement for 'No Artificial Colors' Labeling Claims and Expands Approval of Two Naturally Derived Color Additives

Perkins Coie on

On February 5, 2026, the U.S. Food and Drug Administration (FDA) announced that food manufacturers will now have greater flexibility to use a “no artificial colors” claim when the products do not contain petroleum-based...more

61,085 Results
 / 
View per page
Page: of 2,444

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide